Finepoint Capital LP Q3 2024 Filing
Filed November 13, 2024
Portfolio Value
$1.4T
Holdings
26
Report Date
Q3 2024
Filing Type
13F-HR
All Holdings (26 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | QXOQXO INC | 25,750,781 | $406.1B | 29.51% | |
| 2 | SPYSPDR S&P 500 ETF TR | 555,000 | $318.4B | 23.14% | Put |
| 3 | IWMISHARES TR | 1,065,000 | $235.2B | 17.10% | Put |
| 4 | LBRDKLiberty Broadband Corp | 1,994,510 | $154.2B | 11.20% | |
| 5 | RVMDREVOLUTION MEDICINES INC | 731,960 | $33.2B | 2.41% | |
| 6 | ARGXArgenx SE | 54,428 | $29.5B | 2.14% | |
| 7 | ASNDASCENDIS PHARMA A/S | 190,072 | $28.4B | 2.06% | |
| 8 | TVTXTRAVERE THERAPEUTICS INC | 1,782,267 | $24.9B | 1.81% | |
| 9 | SWTXSPRINGWORKS THERAPEUTICS INC | 650,852 | $20.9B | 1.52% | |
| 10 | MLTXMoonLake Immunotherapeutics | 388,835 | $19.6B | 1.42% | |
| 11 | SRPTSAREPTA THERAPEUTICS INC | 133,535 | $16.7B | 1.21% | |
| 12 | GLPGGALAPAGOS NV | 557,762 | $16.1B | 1.17% | |
| 13 | ARVNARVINAS INC | 574,378 | $14.1B | 1.03% | |
| 14 | ACADACADIA PHARMACEUTICALS INC | 905,384 | $13.9B | 1.01% | |
| 15 | CYTKCYTOKINETICS INC | 256,449 | $13.5B | 0.98% | |
| 16 | RLAYRELAY THERAPEUTICS INC | 1,626,146 | $11.5B | 0.84% | |
| 17 | PRTAPROTHENA CORP PLC | 433,471 | $7.3B | 0.53% | |
| 18 | SLDBSOLID BIOSCIENCES INC | 961,251 | $6.7B | 0.49% | |
| 19 | EYPTEYEPOINT PHARMACEUTICALS INC | 707,404 | $5.7B | 0.41% | |
| 20 | —Swiftmerge Acquisition Corp | 490,000 | $39.2M | 0.00% | |
| 21 | CDAQFCompass Digital Acquisition Corp | 459,906 | $28.1M | 0.00% | |
| 22 | —MONEYHERO LIMITED | 895,000 | $26.9M | 0.00% | |
| 23 | —Marblegate Acquisition Corp | 735,000 | $25.3M | 0.00% | |
| 24 | —LAKESHORE BIOPHARMA CO LTD | 489,999 | $24.2M | 0.00% | |
| 25 | CLDICALIDI BIOTHERAPEUTICS INC | 12,500 | $14.2M | 0.00% | |
| 26 | CLDWWCALIDI BIOTHERAPEUTICS INC | 655,200 | $8.6M | 0.00% |